STC2 expression was found to be associated with hepatocellular carcinoma tumor microsatellite instability in our study, which may provide a further therapeutic strategy for immunotherapy of hepatocellular carcinoma patients. This evidence concerns the gene STC2 and hepatocellular carcinoma.